Three-year outcomes after Aquablation therapy compared to TURP: results from a blinded randomized trial
Peter Gilling1, Neil Barber2, Mohamed Bidair3, Paul Anderson4, Mark Sutton5, Tev Aho6, Eugene Kramolowsky7, Andrew Thomas8, Barrett Cowan9, Ronald P. Kaufman, Jr.10, Andrew Trainer11, Andrew Arther11, Gopal Badlani12, Mark Plante13, Mihir Desai14, Leo Doumanian14, Alexis E. Te15, Mark DeGuenther16, Claus Roehrborn17
Canadian Journal of Urology, Vol.27, No.1, pp. 10072-10079, 2020
Abstract Introduction: To compare 3-year efficacy and safety after prostate resection with Aquablation therapy or transurethral resection of the prostate (TURP) for the treatment of lower urinary tract symptoms related to benign prostate hyperplasia (BPH).
Materials and methods: One hundred and eighty-one patients assigned to either Aquablation therapy or TURP were followed for 3 years postoperatively. Patients and follow-up assessors were blinded to treatment. Assessments included International Prostate Symptom Score (IPSS), Male Sexual Health Questionnaire (MSHQ-EjD), International Index of Erectile Function (IIEF) and uroflow.
Results: Over 3 years of treatment, improvements in IPSS scores were statistically similar across groups.… More >